How much does Retifanlimab cost? Market price in 2025

Retifanlimab (Retifanlimab) is a new immune checkpoint inhibitor with a relatively high price. Riflimab is sold under the brand name ZYNYZ in the U.S. market, with a dosage of 500mg/20ml per box and a price of approximately RMB 100,000. This price reflects the high cost of reflimab as an innovative biologic drug. It is a drug that improves the anti-cancer ability of the immune system by blocking PD-1 receptors. It is widely used to treat advanced or metastatic Merkel cell carcinoma (MCC), etc., especially in the field of immunotherapy.

Since Riflimab has not yet been launched in China, Chinese patients currently cannot purchase the drug directly from pharmacies, and it is not covered by domestic medical insurance. At present, the price of immunotherapy drugs on the Chinese market is generally high, and as a new type of immunotherapy drug, refulimab is also relatively expensive. If patients choose to purchase Riflimab from overseas, the price may fluctuate due to exchange rate changes and import charges.

In addition, the high price of Riflimab is mainly due to its complex production process and the cost of research and development of innovative drugs. Among immunotherapy drugs, reflimab is similar to other PD-1 inhibitors (such as nivolumab, pembrolizumab, etc.), but the price and effectiveness of each drug are different. With the continuous development of immunotherapy drugs, the treatment market for Riflimab may gradually expand, and generic drugs may appear, which may lower its price. Especially in other regions or economically developing low-income countries, drug prices may become more affordable.

In general, as an immunotherapy drug, although its price is higher, riflimab has shown significant efficacy in treating refractory tumors, making it an important treatment option for some patients. With the development of the drug market in the future, the price of Riflimab may gradually change, and patients can also find a treatment plan that suits them through different channels.

Reference materials:https://www.drugs.com/mtm/retifanlimab.html